Spectral computed tomography with inorganic nanomaterials: State-of-the-art

Adv Drug Deliv Rev. 2022 Oct:189:114524. doi: 10.1016/j.addr.2022.114524. Epub 2022 Sep 2.

Abstract

Recently, spectral computed tomography (CT) technology has received great interest in the field of radiology. Spectral CT imaging utilizes the distinct, energy-dependent X-ray absorption properties of substances in order to provide additional imaging information. Dual-energy CT and multi-energy CT (Spectral CT) are capable of constructing monochromatic energy images, material separation images, energy spectrum curves, constructing effective atomic number maps, and more. However, poor contrast, due to neighboring X-ray attenuation of organs and tissues, is still a challenge to spectral CT. Hence, contrast agents (CAs) are applied for better differentiation of a given region of interest (ROI). Currently, many different kinds of inorganic nanoparticulate CAs for spectral CT have been developed due to the limitations of clinical iodine (I)-based contrast media, leading to the conclusion that inorganic nanomedicine applied to spectral CT will be a powerful collaboration both in basic research and in clinics. In this review, the underlying principles and types of spectral CT techniques are discussed, and some evolving clinical diagnosis applications of spectral CT techniques are introduced. In particular, recent developments in inorganic CAs used for spectral CT are summarized. Finally, the challenges and future developments of inorganic nanomedicine in spectral CT are briefly discussed.

Keywords: Clinical applications; Contrast agents; Dual-energy computed tomography; Inorganic nanoparticles; Spectral computed tomography.

Publication types

  • Review
  • Research Support, Non-U.S. Gov't

MeSH terms

  • Contrast Media*
  • Humans
  • Iodine*
  • Tomography, X-Ray Computed / methods

Substances

  • Contrast Media
  • Iodine